Steven Cohen Karuna Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $45.6 Million - $90 Million	-283,170 Reduced 81.42%	64,630 $20.5 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $49.7 Million - $65.8 Million	301,860 Added 657.07%	347,800 $58.8 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $91.3 Million - $124 Million	-517,558 Reduced 91.85%	45,940 $9.96 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $78.5 Million - $99.4 Million	486,506 Added 631.89%	563,498 $102 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $36.6 Million - $45.3 Million	-191,108 Reduced 71.28%	76,992 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $33.2 Million - $74.4 Million	268,100 New	268,100 $60.3 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $18 Million - $27.5 Million	-191,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $9.76 Million - $13.1 Million	98,703 Added 106.02%	191,800 $24.3 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $10.3 Million - $14.8 Million	93,097 New	93,097 $12.2 Million
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $431,711 - $4.68 Million	-37,737 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$16.05 - $27.35 $605,678 - $1.03 Million	37,737 New	37,737 $616,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.